Chest CT features associated with the clinical characteristics of patients with COVID-19 pneumonia

Ruichao Niu1, Shuming Ye2, Yongfeng Li3

  • 1Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, PR China.

Annals of Medicine
|January 11, 2021
PubMed

Insights

Chest CT scans reveal distinct patterns in COVID-19 patients, aiding in prognosis. Nodular patterns often indicate non-severe cases with better outcomes, while mixed patterns suggest severe disease and poorer prognosis.

Area of Science:

  • Radiology
  • Infectious Diseases
  • Pulmonology

Background:

  • Coronavirus disease 2019 (COVID-19) is a global pandemic.
  • Chest CT imaging is crucial for diagnosing and monitoring COVID-19.
  • Understanding CT findings' correlation with clinical characteristics is vital.

Purpose of the Study:

  • To investigate the relationship between chest CT findings and clinical characteristics in COVID-19 patients.
  • To explore how CT features correlate with disease severity and prognosis.

Main Methods:

  • Retrospective enrollment of 361 COVID-19 patients confirmed by RT-PCR or next-generation sequencing.
  • Analysis of serial chest CT procedures (more than 4 per patient).
  • Categorization of CT findings including ground-glass opacities, consolidation, nodules, fibrous stripes, and mixed patterns.

Main Results:

  • Initial CT scans showed bilateral lung lesions, predominantly peripheral.
  • Ground-glass opacities (28.5%), nodules (23.0%), and mixed patterns (30.2%) were common.
  • Mixed patterns were associated with severe cases (21.1%), while nodules were linked to non-severe cases (2.4%).
  • Follow-up CT revealed significantly lower total severity scores for nodular and fibrous stripe patterns compared to mixed patterns (p < .01).

Conclusions:

  • Chest CT findings are instrumental in diagnosing and predicting COVID-19 patient outcomes.
  • Nodular CT patterns correlate with non-severe cases and favorable prognosis.
  • Mixed CT patterns are more frequent in severe cases, indicating a poorer prognosis.
Abstract

Related Concept Videos

Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
145
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.6K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.8K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
610
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.2K
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
612